Clinical trial
Effects of Treatment Changes on Fat Wasting in the Arms and Legs of HIV Patients
NCT00028314 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00028314 |
|---|---|
| Title | Effects of Treatment Changes on Fat Wasting in the Arms and Legs of HIV Patients |
| Official title | A Restrictively Randomized, Open-Label, Controlled, Pilot Study of the Effect of a Thymidine Analogue Substitution or Change to a Nucleoside-Sparing Regimen on Peripheral Fat Wasting |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | HIV Infections, Lipodystrophy, Wasting Disease |
| Intervention type | Drug |
| Interventions | Abacavir sulfate, Atazanavir/Ritonavir, Lopinavir/Ritonavir, Nevirapine |
| Enrollment | 150 |
| Start date | Mar 1, 2002 |
| Completion | Mar 1, 2005 |
| First posted | Dec 21, 2001 |
| Last update posted | Jul 29, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: